Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3CD | O00329 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL195053 | 0.84 | — | — | |
| SCHEMBL532337 | 0.81 | — | — | |
| SCHEMBL867834 | 0.80 | PIK3CD (0.33) | PIK3CD | |
| SCHEMBL35531 | 0.77 | PIK3CD (0.35) | PIK3CD | |
| SCHEMBL996315 | 0.76 | CHRM2 (0.38) | PIK3CD | |
| SCHEMBL35410 | 0.73 | ALDH1A1 (0.34) | — | |
| SCHEMBL5160713 | 0.72 | RAB9A (0.37) | — | |
| SCHEMBL10033658 | 0.71 | — | — | |
| SCHEMBL632087 | 0.69 | FAAH (0.32) | PIK3CD | |
| SCHEMBL18570239 | 0.69 | PIK3CD (0.32) | PIK3CD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 252 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4707315-A1 | COPOLYMER, COMPOSITION AND USE THEREOF | Beijing Mapu New Materials Co., Ltd. (CN) | 2026-03-11 | — | — | EP | claimed |
| EP-4688899-A1 | RADIATION CURABLE COMPOSITION | Allnex USA Inc. (US) | 2026-02-11 | — | — | EP | claimed |
| WO-2024245366-A1 | COPOLYMER, COMPOSITION AND USE THEREOF | 北京马普新材料有限公司 | 2024-12-05 | — | — | WO | claimed |
| WO-2024206279-A1 | RADIATION CURABLE COMPOSITION | ALLNEX USA INC. (US) | 2024-10-03 | — | — | WO | claimed |
| CN-116874664-A | Copolymer for paper product treatment, treatment method and product | 北京马普新材料有限公司 | 2023-10-13 | — | — | CN | claimed |
| CN-116789898-A | Copolymer, composition and application thereof | 北京马普新材料有限公司 | 2023-09-22 | — | — | CN | claimed |
| CN-107531850-B | Use of a composition for bleaching teeth | 巴斯夫欧洲公司 | 2022-01-11 | — | — | CN | claimed |
| EP-3288532-B1 | POLYMERS FOR THE STABILISATION OF PEROXIDE COMPOUNDS | BASF SE (DE) | 2021-06-23 | — | — | EP | claimed |
| US-10752822-B2 | Crosslinked polymer compositions and methods for use in subterranean formation operations | HALLIBURTON ENERGY SERVICES, INC. (US) | 2020-08-25 | — | — | US | claimed |
| EP-3288533-B1 | POLYMERS FOR THE STABILISATION OF PEROXIDE LINKS | BASF SE (DE) | 2020-08-19 | — | — | EP | claimed |
| US-8895478-B2 | Degradable polymer compositions and uses thereof | ISP INVESTMENTS INC. (US) | 2014-11-25 | — | — | US | claimed |
| CN-101720239-B | Implant device release agent and method of use thereof | ENDO PHARMACEUTICALS SOLUTIONS | 2013-12-04 | — | — | CN | claimed |
| US-20120301522-A1 | PEROXIDE-STABILIZED ABRASIVE TOOTH WHITENING COMPOSITIONS, PROCESS FOR PREPARING AND METHOD OF USE | ISP INVESTMENTS INC. (US) | 2012-11-29 | — | — | US | claimed |
| US-20120157352-A1 | DEGRADABLE POLYMER COMPOSITIONS AND USES THEREOF | ISP INVESTMENTS INC. (US) | 2012-06-21 | — | — | US | claimed |
| US-20120077717-A1 | Polymers Having N-Vinyl Amide And Hydroxyl Moieties, Their Compositions And The Uses Thereof | ISP INVESTMENTS INC. (US) | 2012-03-29 | — | — | US | claimed |
| US-20110277844-A1 | POLYMERS DERIVED FROM N-VINYL FORMAMIDE, VINYL AMIDES OR ACRYLAMIDES, AND REACTION SOLVENT, AND THE USES THEREOF | HERCULES LLC | 2011-11-17 | — | — | US | claimed |
| CN-101720239-A | Implant device release agent and method of use thereof | ENDO PHARMACEUTICALS SOLUTIONS | 2010-06-02 | — | — | CN | claimed |
| EP-2139533-A2 | IMPLANT DEVICE RELEASE AGENTS AND METHODS OF USING SAME | Endo Pharmaceuticals Solutions Inc. (US) | 2010-01-06 | — | — | EP | claimed |
| US-20080311170-A1 | IMPLANT DEVICE RELEASE AGENTS AND METHODS OF USING SAME | INDEVUS PHARMACEUTICALS, INC. | 2008-12-18 | — | — | US | claimed |
| WO-2008134475-A2 | IMPLANT DEVICE RELEASE AGENTS AND METHODS OF USING SAME | ENDO PHARMACEUTICALS SOLUTIONS INC., 33 (US) | 2008-11-06 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080311170-A1 | IMPLANT DEVICE RELEASE AGENTS AND METHODS OF USING SAME | PTGES, VDR, HPGDS | PIK3CD 3373/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.